We continue to make strides in terms of increasing public awareness of perinatal mood and anxiety disorders, but we still have a long way to go when it comes to providing access to mental health [...]
Pregnancy-associated mortality, defined as the death of a woman during pregnancy or within one year of the termination of pregnancy, is increasing in Massachusetts. In 2012, there were 30.4 deaths/100,000 live births. In 2014, the [...]
Because folate deficiency in pregnant women has been associated with an increased risk of neural tube defects, including anencephaly and spina bifida, it is recommended that all women take folic acid supplements before and during [...]
Pregabalin (marketed in the US as Lyrica) is approved by the US Food and Drug Administration for the treatment of epilepsy, fibromyalgia, and neuropathic pain. It is also used off-label to treat psychiatric disorders, most [...]
Our group will be traveling to Albany, New York this Friday, October 12th, to take part in the New York State Conference on Maternal Depression sponsored by Project TEACH. We will be joining our colleagues [...]
The American College of Obstetrics and Gynecology now recommends that women be screened for depression during pregnancy in addition to screening during the postpartum period. Because depressive symptoms during pregnancy have been associated with worse [...]
A recent article published in JAMA Internal Medicine raises concerns regarding the increasing use of marijuana in pregnant women. According to data derived from two small surveys, women reported using marijuana to alleviate morning sickness, [...]
The newer “atypical” or second-generation antipsychotic agents are now used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders. The National Pregnancy Registry for Atypical Antipsychotics [...]
Recent studies have demonstrated that more than 10% of women experience clinically significant symptoms of anxiety during pregnancy, particularly during the first trimester. Anxiety during pregnancy is not necessarily a benign event. Various studies indicate [...]
Over the last ten or so years, we have noticed a significant increase in the use of ondansetron (marketed as Zofiran) for the treatment of nausea and vomiting during pregnancy (NVP). In a recent issue [...]